Nov 12, 2019   SOURCE: PR NewsWire

Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis - 2019 Market Research Report

DUBLIN, Nov. 12, 2019 /PRNewswire/ -- The "Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

In the future, a variety of conditions may be diagnosed with a simple breath test. Researchers are looking beyond blood tests and solid/liquid biopsies to find other sources of information to diagnose disease. Every time an individual breathes, thousands of volatile organic compounds (VOCs) and volatile fatty acids (VFAs), the breakdown products of lipids and proteins,1 are released into the breath. These novel biomarkers are by-products of metabolism, and can provide a snapshot of an individual's health.

Report Includes:

    --  Detailed discussion on the breath as a snapshot of an individuals'
        health
    --  Assessment of the role of breath biopsy in drug development, diagnosis,
        and treatment of respiratory diseases, cancer, metabolic disorders, and
        CNS diseases
    --  Discussion about proton-transfer-reaction time-of-flight mass
        spectrometry (PTR-ToF-MS), gas chromatography time-of-flight mass
        spectrometers (GC-TOF-MS) and field asymmetric ion mobility spectrometry
        (FAIMS)
    --  Coverage of latest developments in-breath biopsy research & analysis and
        strategies adopted by institutes and start-up companies to identify and
        enhance breath biopsy in drug development

Key Topics Covered:

Chapter 1 Monitoring Volatile Organic Compounds

    --  Introduction
    --  Analyst's Credentials
    --  Custom Research
    --  Related Reports

Chapter 2 Value Proposition of Breath Testing

    --  Value Proposition of Breath Testing
    --  Technological Advances in Analytical Techniques
    --  Technological Advances in Breath Collection

Chapter 3 Applications in Diagnostics

    --  Identifying Food Intolerances
    --  Guiding Asthma Treatment Decisions
    --  Early Detection of Gastroesophageal and Lung Cancer
    --  Diagnosing of Liver Disease and Personalizing Treatment
    --  Breath Biopsy Could Revolutionize MS Diagnosis
    --  Challenges for the Future Development of Breath Biopsies
    --  The Future for Breath Biopsies

Chapter 4 Companies and Technologies for Which to Watch Out

    --  Algernon Pharmaceuticals
    --  Bedfont Scientific Breath Analyzers
    --  Breath Diagnostics OneBreath Test
    --  Cairn Diagnostics' 13C-Spirulina GEBT
    --  Circassia's NIOX range
    --  Ekips Technologies Breathmeter
    --  Exalenz Biosciences' BreathID Systems
    --  Menssana Research's BreathLink
    --  Metabolic Solutions Gut-Chek
    --  New England Breath Technologies Glucair
    --  Owlstone Medical's ReCIVA

Chapter 5 References

For more information about this report visit https://www.researchandmarkets.com/r/nzo1ce

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/breath-biopsies-a-revolutionary-approach-for-noninvasive-diagnosis---2019-market-research-report-300956364.html

SOURCE Research and Markets